Parmar Kush's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Aug 3, 2026
- Accession no.
- 0001664281-26-000002
- Filed
- Aug 3, 2026, 5:26 PM ET
- Trade date
- Jul 30-31, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $807.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parmar KushCIK 0001664281 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | SSaleDisposed | −114,756 | $6.93 | −$795,259.08 | 2,848,310 | Indirect | |
| Jul 31, 2026 | Common Stock | SSaleDisposed | −1,718 | $6.85 | −$11,768.3 | 2,846,592 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.